China Adds CTD and DMF Filing Requirements to Enhance Drug Quality
This article was originally published in The Gold Sheet
Executive Summary
SHANGHAI – China’s State FDA recently issued a note to provincial FDA offices to require pharma companies and active pharmaceutical ingredient producers to file a Common Technical Document when they submit manufacturing applications as an effort to improve drug quality and research and development work in China.
You may also be interested in...
U.S. FDA China Country Head Chris Hickey On FDA's Mission In China: An Interview With PharmAsia News (Part 2 of 2)
U.S.FDA established offices in China in 2008 to improve oversight of products exported to the U.S., and to establish stronger working relationships with China's State FDA. The mission of the office initially was to implement two export agreements signed with China in December 2007 to enhance regulatory cooperation in the areas of food, drugs, medical devices and animal feed. PharmAsia News' China and Australia bureaus spoke to FDA China Country Director Christopher Hickey about the mission of the China office and progress being made in China. This is part two of a two-part interview; part one appeared in a recent issue of PharmAsia News.
China's SFDA Plans To Release New GMP Guidelines In June To Bring Chinese Pharmas To Global Stage: CPhI China Conference
SHANGHAI - While more than 8 million people have visited the World Expo in Shanghai, more than 1,600 pharma, biotech and active pharmaceutical ingredient providers in China are also gathering in Shanghai for the Expo CPhI
China Issues New Medical Device GMP Standards, Set To Take Effect On New Year's Day Of 2011
BEIJING - China's State FDA has issued a wide-ranging compilation of good manufacturing practice standards for medical devices, set to become effective one year from now, that for the first time will cover all manufacturers across the country, according to lawyers who closely monitor the sector